These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6168111)
1. [Testing the safety of cultural viral vaccines]. Dobrotvortseva VG; Milovidova NI Vopr Virusol; 1981; (2):132-6. PubMed ID: 6168111 [No Abstract] [Full Text] [Related]
2. Evaluation of virus vaccine strains for oncogenicity. Gray A Prog Immunobiol Stand; 1971; 5():259-62. PubMed ID: 4122069 [No Abstract] [Full Text] [Related]
3. Viral oncogenicity and viral vaccines--general comments. Gerber P Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932 [No Abstract] [Full Text] [Related]
4. [Production of oncornaviruses by cell cultures]. Lozinskiĭ TF; Volkova MIa; Abenova UA; Mazurenko NN; Miller GG Vopr Onkol; 1974; 20(1):56-62. PubMed ID: 4140609 [No Abstract] [Full Text] [Related]
5. A consideration of the cell substrates used in human virus vaccine preparation. Hayflick L Prog Immunobiol Stand; 1967; 3():86-93. PubMed ID: 4314442 [No Abstract] [Full Text] [Related]
6. Replication of primate oncornavirus SSV-1 on MRC-5 human diploid cells. Horodniceanu F; Sinoussi F; Chermann JC; Tardy-Panit M; Michelson-Fiske S; Yvert F Dev Biol Stand; 1976 Dec 13-15; 37():201-4. PubMed ID: 73483 [TBL] [Abstract][Full Text] [Related]
7. [Detection of latent viruses and Mycoplasma by the methods of molecular biology]. Lozinskiĭ TF; Gushchin BV; Astakhova AV; Klimenko SM; Zhdanov VM Vopr Virusol; 1974; (4):474-9. PubMed ID: 4612996 [No Abstract] [Full Text] [Related]
8. Tissue and medium antigens in vaccines. Coriell LL Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862 [No Abstract] [Full Text] [Related]
9. The need for a standardised cell substrate for virus vaccine production. Perkins FT Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315 [No Abstract] [Full Text] [Related]
10. Tests for RNA tumor viruses in cell substrates used in virus vaccine production. Petricciani JC; Milstien JB Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485 [TBL] [Abstract][Full Text] [Related]
11. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines. Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757 [No Abstract] [Full Text] [Related]
12. Origin of endogenous and exogenous agents in cell cultures. Hopps HE In Vitro; 1974; 10(5-6):243-6. PubMed ID: 4217763 [No Abstract] [Full Text] [Related]
13. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents. Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389 [No Abstract] [Full Text] [Related]
14. Suggested methods for the management and testing of a passaged diploid cell culture used for virus vaccine production. Perkins FT Jpn J Med Sci Biol; 1971 Oct; 24(5):342-4. PubMed ID: 5316784 [No Abstract] [Full Text] [Related]
16. Mislabeling, contamination, and other sins of cultured flesh. Hayflick L Dev Biol Stand; 1976 Dec 13-15; 37():5-15. PubMed ID: 1031693 [No Abstract] [Full Text] [Related]
17. Viral oncogenicity and viral vaccines--general comments. Rabson AS Natl Cancer Inst Monogr; 1968 Dec; 29():445-6. PubMed ID: 4305435 [No Abstract] [Full Text] [Related]
18. Neoplastic properties of animal cell lines--general comments. Macpherson I Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360 [No Abstract] [Full Text] [Related]
19. Monitoring vaccines for human oncogenicity. Miller RW Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436 [No Abstract] [Full Text] [Related]
20. Nonhuman primate diploid cells for vaccine production. Petricciani JC Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]